logo

For the Inventor, By the Inventor

Marburg, Germany

Peter Hermentin

This inventor holds 17 USPTO granted patents, plus 4 CIPO patents, primarily in Biopolymer Research. Top assignees: Behringwerke Aktiengesellschaft, Behring Diagnostics Gmbh, Aventis Pharma Deutschland, Gmbh. Active years: 1990-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter Hermentin. Retrieved from https://idiyas.com/inventor/peter-hermentin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 17

% Patents Active = 94.1

 

Average Co-Inventor Count = 2.8

ph-index = 4

Forward Citations = 455(Granted Patents)


Company Filing History:

goldMedal10 out of 340 
 
Behringwerke Aktiengesellschaft
 patents
silverMedal4 out of 39 
 
Behring Diagnostics Gmbh
 patents
bronzeMedal1 out of 330 
 
Aventis Pharma Deutschland, Gmbh
 patents
4. 1 out of 149 
 
Dade Behring Marburg Gmbh
 patents
5. 1 out of 834,708 
Other
 patents

Years Active: 1990-2012

Loading Chart...
Loading Chart...
Areas of Expertise:
Sialoglycoproteins
Glycosylation
Monoclonal Antibodies
Heavy Metals Removal
Biopolymer Conjugates
Immunoassays
Anthracycline Derivatives
Protein Conjugates
Leucine Zipper Peptides
Cytostatic Activity
Effector Substances
Complexing Agents
17 patents (USPTO):Explore Patents
1. 8150630 - Method for characterisation of the quality of sialoglycoproteins via an isoform number I (2012-04-03),
2. 6673609 - Recombinant human erythropoietin with advantageous glycosylation profile (2004-01-06),
3. 6096555 - Process for characterizing the glycosylation of glyco-proteins and for (2000-08-01),
4. 5908790 - Methods for removing heavy metals from aqueous solutions and for analysis (1999-06-01),
5. 5907034 - Monoclonal antibody against complexed and non-complexed complexing (1999-05-25),
6. 5773271 - Compounds from biopolymers and effector substances which are linked via (1998-06-30),
7. 5744315 - Compounds from biopolymers and effector substances which are linked via (1998-04-28),
8. 5672687 - Magnetic protein conjugates, a process for the preparation thereof, and (1997-09-30),
9. 5643731 - Use of pairs of leucine zipper peptides in immunoassay methods (1997-07-01),
10. 5591828 - Bispecific and oligospecific mono-and oligovalent receptors, the (1997-01-07),
11. 5484722 - Biopolymer and effector substance conjugates, process for the (1996-01-16),
12. 5321142 - Compounds from biopolymers and effector substances which are linked via (1994-06-14),
13. 5260425 - Anthracycline derivatives having cytostatic activity (1993-11-09),
14. 5095097 - Magnetic protein conjugates, a process for the preparation thereof and (1992-03-10),
15. 4965352 - Anthracycline derivatives having cytostatic activity (1990-10-23),

Title: The Innovations of Peter Hermentin

Introduction

Peter Hermentin is a notable inventor based in Marburg, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic glycoproteins. With a total of 17 patents to his name, Hermentin's work has had a profound impact on medical science.

Latest Patents

One of his latest patents is a method for the characterization of the quality of sialoglycoproteins via an isoform number I. This method allows for the assessment of the quality of a sialoglycoprotein based on its isoform distribution, which is determined through capillary electrophoretic analysis. This characterization serves as a quality feature for batch consistency, storage stability, biological half-life, and the biological effectiveness of therapeutic glycoproteins. Another significant patent involves recombinant human erythropoietin with an advantageous glycosylation profile. This method describes the production of a polypeptide by culturing eukaryotic host cells under specific conditions, leading to the isolation of a polypeptide that can be used in pharmaceutical compositions for treating anemia.

Career Highlights

Throughout his career, Peter Hermentin has worked with prominent companies such as Behringwerke Aktiengesellschaft and Behring Diagnostics GmbH. His experience in these organizations has contributed to his expertise in the field of biotechnology and patent development.

Collaborations

Some of his notable coworkers include Heinz-Jurgen Friesen and Klaus Bosslet. Their collaboration has likely fostered innovation and advancement in their shared projects.

Conclusion

Peter Hermentin's contributions to biotechnology through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to influence the development of therapeutic solutions in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…